Abstract
Exposure to peripheral infections may be permissive to cognitive and behavioral complications in the elderly. We have reported that peripheral stimulation of the innate immune system with lipopolysaccharide (LPS) causes an exaggerated neuroinflammatory response and prolonged sickness behavior in aged BALB/c mice. Because LPS also causes depressive behavior, the purpose of this study was to determine whether aging is associated with an exacerbated depressive-like response. We confirmed that LPS (0.33 mg/kg intraperitoneal) induced a protracted sickness response in aged mice with reductions in locomotor and feeding activities 24 and 48 h postinjection, when young adults had fully recovered. When submitted to the forced swim test 24 h post-LPS, both young adult and aged mice exhibited an increased duration of immobility. However, when submitted to either the forced swim test or the tail suspension test 72 h post-LPS, an increased duration of immobility was evident only in aged mice. This prolonged depressive-like behavior in aged LPS-treated mice was associated with a more pronounced induction of peripheral and brain indoleamine 2,3-dioxygenase and a markedly higher turnover rate of brain serotonin (as measured by the ratio of 5-hydroxy-indoleacetic acid over 5-hydroxyt-tryptamine) compared to young adult mice at 24 post-LPS injection. These results provide the first evidence that age-associated reactivity of the brain cytokine system could play a pathophysiological role in the increased prevalence of depression observed in the elderly.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Anisman H, Matheson K (2005). Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 29: 525–546.
Anisman H, Ravindran AV, Griffiths J, Merali Z (1999). Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4: 182–188.
Barrientos RM, Higgins EA, Biedenkapp JC, Sprunger DB, Wright-Hardesty KJ, Watkins LR et al (2006). Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol Aging 27: 723–732.
Behan WM, McDonald M, Darlington LG, Stone TW (1999). Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol 128: 1754–1760.
Berg BM, Godbout JP, Kelley KW, Johnson RW (2004). Alpha-tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice. Brain Behav Immun 18: 149–157.
Capuron L, Dantzer R (2003). Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17 (Suppl 1): S119–S124.
Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D et al (2003). Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment. Biol Psychiatry 54: 906–914.
Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M et al (2001). Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26: 797–808.
Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R (2002). Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7: 468–473.
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386–389.
Chiarugi A, Calvani M, Meli E, Traggiai E, Moroni F (2001). Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages. J Neuroimmunol 120: 190–198.
Chourbaji S, Urani A, Inta I, Sanchis-Segura C, Brandwein C, Zink M et al (2006). IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol Dis 23: 587–594.
Craft TK, DeVries AC (2006). Role of IL-1 in poststroke depressive-like behavior in mice. Biol Psychiatry 60: 812–818.
Dentino AN, Pieper CF, Rao MK, Currie MS, Harris T, Blazer DG et al (1999). Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 47: 6–11.
Dunn AJ (1992). Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J Pharmacol Exp Ther 261: 964–969.
Dunn AJ, Swiergiel AH (2005). Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Behav 81: 688–693.
Dunn AJ, Swiergiel AH, de Beaurepaire R (2005). Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 29: 891–909.
Frank MG, Barrientos RM, Biedenkapp JC, Rudy JW, Watkins LR, Maier SF (2006). mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol Aging 27: 717–722.
Frenois F, Moreau M, O'Connor J, Lawson M, Micon C, Lestage J et al (2007). Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32: 516–531.
Glaser R, Kiecolt-Glaser JK (2005). Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 5: 243–251.
Glaser R, Robles TF, Sheridan J, Malarkey WB, Kiecolt-Glaser JK (2003). Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry 60: 1009–1014.
Godbout JP, Berg BM, Kelley KW, Johnson RW (2004). Alpha-tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain. J Neuroimmunol 149: 101–109.
Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, Kelley KW et al (2005). Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J 19: 1329–1331.
Godbout JP, Johnson RW (2006). Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Neurol Clin 24: 521–538.
Guillemin GJ, Smythe G, Takikawa O, Brew BJ (2005). Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49: 15–23.
Heyes MP, Saito K, Chen CY, Proescholdt MG, Nowak Jr TS, Li J et al (1997). Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation. J Neurochem 69: 1519–1529.
Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP (2007). Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging, e-pub ahead of print.
Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R (2003). Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 100: 9090–9095.
Lee CK, Klopp RG, Weindruch R, Prolla TA (1999). Gene expression profile of aging and its retardation by caloric restriction. Science 285: 1390–1393.
Lee CK, Weindruch R, Prolla TA (2000). Gene-expression profile of the ageing brain in mice. Nat Genet 25: 294–297.
Lesch KP (2001). Serotonergic gene expression and depression: implications for developing novel antidepressants. J Affect Disord 62: 57–76.
Lestage J, Verrier D, Palin K, Dantzer R (2002). The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav Immun 16: 596–601.
Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V (1999). Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40: 171–176.
Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH et al (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54: 960–971.
Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402–408.
Maes M, Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M et al (2001). Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation. Mol Psychiatry 6: 475–480.
Mattson MP, Maudsley S, Martin B (2004). BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 27: 589–594.
Millan MJ (2006). Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110: 135–370.
Moreau M, Lestage J, Verrier D, Mormede C, Kelley KW, Dantzer R et al (2005). Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J Infect Dis 192: 537–544.
Mulsant BH, Ganguli M (1999). Epidemiology and diagnosis of depression in late life. J Clin Psychiatry 60 (Suppl 20): 9–15.
O'Connor J, Lawson M, Andre C, Moreau M, Lestage J, Castanon N et al (2007). Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3 dioxygenase activation in mice. Mol Psychiatry (in press).
Okuda S, Nishiyama N, Saito H, Katsuki H (1998). 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70: 299–307.
Penninx BW, Geerlings SW, Deeg DJ, van Eijk JT, van Tilburg W, Beekman AT (1999). Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry 56: 889–895.
Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S et al (2003). Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 54: 566–572.
Perry VH, Cunningham C, Holmes C (2007). Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 7: 161–167.
Perry VH, Matyszak MK, Fearn S (1993). Altered antigen expression of microglia in the aged rodent CNS. Glia 7: 60–67.
Pollmacher T, Haack M, Schuld A, Reichenberg A, Yirmiya R (2002). Low levels of circulating inflammatory cytokines—do they affect human brain functions? Brain Behav Immun 16: 525–532.
Porsolt RD (2000). Animal models of depression: utility for transgenic research. Rev Neurosci 11: 53–58.
Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27: 24–31.
Richwine AF, Godbout JP, Berg BM, Chen J, Escobar J, Millard DK et al (2005). Improved psychomotor performance in aged mice fed diet high in antioxidants is associated with reduced ex vivo brain interleukin-6 production. Brain Behav Immun 19: 512–520.
Saito K, Crowley JS, Markey SP, Heyes MP (1993a). A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J Biol Chem 268: 15496–15503.
Saito K, Nowak Jr TS, Suyama K, Quearry BJ, Saito M, Crowley JS et al (1993b). Kynurenine pathway enzymes in brain: responses to ischemic brain injury vs systemic immune activation. J Neurochem 61: 2061–2070.
Schiepers OJ, Wichers MC, Maes M (2005). Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29: 201–217.
Sheffield LG, Berman NE (1998). Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol Aging 19: 47–55.
Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K (1995). Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762: 474–476.
Stockmeier CA (2003). Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res 37: 357–373.
Streit WJ, Sparks DL (1997). Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J Mol Med 75: 130–138.
Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT (2005). Increase in interleukin-1beta in late-life depression. Am J Psychiatry 162: 175–177.
Wang J, Dunn AJ (1998). Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem Int 33: 143–154.
Wang J, Dunn AJ (1999). The role of interleukin-6 in the activation of the hypothalamo–pituitary–adrenocortical axis and brain indoleamines by endotoxin and interleukin-1 beta. Brain Res 815: 337–348.
Wichers MC, Maes M (2004). The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J Psychiatry Neurosci 29: 11–17.
Wirleitner B, Rudzite V, Neurauter G, Murr C, Kalnins U, Erglis A et al (2003). Immune activation and degradation of tryptophan in coronary heart disease. Eur J Clin Invest 33: 550–554.
Ye SM, Johnson RW (1999). Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol 93: 139–148.
Zhang J, Terreni L, De Simoni MG, Dunn AJ (2001). Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum. Neurochem Int 38: 303–308.
Acknowledgements
This research was supported by the American Federation for Aging Research (AFAR) grant to JPG and the NIH grants (MH076786) to JPG, (AG029573) to KWK, (MH071349 and MH079829) to RD, and (AG16710 and MH069148) to RWJ.
Author information
Authors and Affiliations
Corresponding author
Additional information
DISCLOSURE/CONFLICT OF INTEREST
The authors declare that there are no actual or potential conflicts of interest. The authors affirm that there are no financial, personal, or other relationships with other people or organizations that have inappropriately influenced or biased their research.
Rights and permissions
About this article
Cite this article
Godbout, J., Moreau, M., Lestage, J. et al. Aging Exacerbates Depressive-like Behavior in Mice in Response to Activation of the Peripheral Innate Immune System. Neuropsychopharmacol 33, 2341–2351 (2008). https://doi.org/10.1038/sj.npp.1301649
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1301649
Keywords
This article is cited by
-
The neuroimmunology of social-stress-induced sensitization
Nature Immunology (2022)
-
Young Plasma Induces Antidepressant-Like Effects in Aged Rats Subjected to Chronic Mild Stress by Suppressing Indoleamine 2,3-Dioxygenase Enzyme and Kynurenine Pathway in the Prefrontal Cortex
Neurochemical Research (2022)
-
Is there a need for consensus in aging biology?
Biology & Philosophy (2022)
-
AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury
Journal of Neuroinflammation (2021)
-
A new experimental design to study inflammation-related versus non-inflammation-related depression in mice
Journal of Neuroinflammation (2021)
